CPE
CPE (carboxypeptidase E) is an M14 family metallocarboxypeptidase that processes peptide hormone precursors in neuro/endocrine cells. It also acts as a sorting receptor, directing prohormones into the regulated secretory pathway. Browse Assay Genie's current range of CPE research reagents below, or read on for the biology behind the target.
CPE has two recognised roles. As a prohormone processing enzyme in neuro/endocrine cells, it removes dibasic residues from the C-terminal end of peptide hormone precursors after an initial endoprotease cleavage. This step is part of the biosynthesis of peptide hormones and neurotransmitters, including insulin. CPE is also described as a sorting receptor that directs prohormones to the regulated secretory pathway, binding regulated secretory pathway proteins, including prohormones.
The CPE gene encodes a member of the M14 family of metallocarboxypeptidases, and the enzyme is classified as EC 3.4.17.10. The encoded preproprotein is proteolytically processed to generate the mature peptidase, a peripheral membrane protein that cleaves C-terminal amino acid residues. UniProt annotates the protein in secretory vesicles, in the secretory vesicle membrane and as a secreted form. HGNC places the gene in the M14 carboxypeptidases group and also among the microRNA protein coding host genes.
The NCBI Gene summary notes that CPE may also function independently of its peptidase activity, as a neurotrophic factor that promotes neuronal survival. Mutations in the CPE gene are implicated in type 2 diabetes. Researchers studying CPE therefore often work across peptide hormone biosynthesis, secretory pathway sorting and neuronal biology. Orthologues are annotated in mouse and rat, both named Cpe.
CPE removes C-terminal dibasic residues from hormone precursors after endoprotease cleavage, making it central to studies of prohormone maturation in neuro/endocrine cells.
CPE acts as a sorting receptor that binds prohormones and directs them into the regulated secretory pathway, a focus for trafficking research.
CPE contributes to insulin biosynthesis, and mutations in the gene are implicated in type 2 diabetes.
CPE may act independently of its peptidase activity as a neurotrophic factor that promotes neuronal survival, opening questions in neurobiology.
CPE removes dibasic residues from the C-terminal end of peptide hormone precursors after initial endoprotease cleavage, in neuro/endocrine cells. It also acts as a sorting receptor that directs prohormones to the regulated secretory pathway, and it contributes to insulin biosynthesis.
The CPE gene encodes carboxypeptidase E, a member of the peptidase M14 family of metallocarboxypeptidases (EC 3.4.17.10). The preproprotein is proteolytically processed into the mature peptidase, which is a peripheral membrane protein. No alternative symbols or previous names are listed by HGNC.
Mutations in the CPE gene are implicated in type 2 diabetes, according to the NCBI Gene summary. Orthologues named Cpe exist in mouse and rat. Check the datasheet of any product for its validated reactivity.
Peptide hormone precursor fragments and other targets with similar names that have products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P16870; product specifications from Assay Genie datasheets.